120 related articles for article (PubMed ID: 3491864)
1. [Clinical aspects of hyper- and hypo-mineralocorticoidism].
Takeda R
Nihon Naika Gakkai Zasshi; 1986 Sep; 75(9):1189-203. PubMed ID: 3491864
[No Abstract] [Full Text] [Related]
2. Clinical aspects of hyper- and hypo-mineralocorticoidism.
Takeda R
Jpn J Med; 1987 Feb; 26(1):91-5. PubMed ID: 3494874
[No Abstract] [Full Text] [Related]
3. Adrenal minerlocorticoids pathway and its clinical applications.
Ghulam A; Vantyghem MC; Wemeau JL; Boersma A
Clin Chim Acta; 2003 Apr; 330(1-2):99-110. PubMed ID: 12636928
[No Abstract] [Full Text] [Related]
4. Spectrum of mineralocorticoid hypertension.
Biglieri EG
Hypertension; 1991 Feb; 17(2):251-61. PubMed ID: 1846843
[No Abstract] [Full Text] [Related]
5. An approach to mineralocorticoid hormone hypertension.
Biglieri EG
Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
[No Abstract] [Full Text] [Related]
6. Childhood hypertension due to adrenocortical disorders.
Oberfield SE; Levine LS; New MI
Pediatr Ann; 1982 Jul; 11(7):623-6, 628. PubMed ID: 6287390
[No Abstract] [Full Text] [Related]
7. Mineralocorticoid hormones.
Stockigt JR
Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
[No Abstract] [Full Text] [Related]
8. [Primary aldosteronism].
Veyrat R; Grandchamp A; Scholer D; Muller AF
Schweiz Med Wochenschr; 1970 Oct; 100(40):1671-7. PubMed ID: 5524978
[No Abstract] [Full Text] [Related]
9. Adrenal mineralocorticoids causing hypertension.
Biglieri EG; Stockigt JR; Schambelan M
Am J Med; 1972 May; 52(5):623-32. PubMed ID: 4556934
[No Abstract] [Full Text] [Related]
10. [Clinical studies on a disorder of mineralocorticoid metabolism].
Takeda R
Nihon Naika Gakkai Zasshi; 1986 Feb; 75(2):164-6. PubMed ID: 3519807
[No Abstract] [Full Text] [Related]
11. 17 Alpha-hydroxylase deficiency.
Biglieri EG
J Endocrinol Invest; 1995; 18(7):540-4. PubMed ID: 9221272
[No Abstract] [Full Text] [Related]
12. The role of adrenal mineralocorticoids in hypertension.
Tuck M
Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928
[No Abstract] [Full Text] [Related]
13. In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn's adenoma tissues.
Bogdan A; Auzéby A; Plouin PF; Touitou Y
J Endocrinol Invest; 1993 Jan; 16(1):65-8. PubMed ID: 8445158
[TBL] [Abstract][Full Text] [Related]
14. Potassium metabolism and hypertension.
Uribarri J; Carroll HJ
J Clin Hypertens; 1985 Dec; 1(4):283-94. PubMed ID: 3014078
[No Abstract] [Full Text] [Related]
15. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
16. [Mineralocorticoid function of the adrenal cortex under normal conditions and in pathology (review of the literature)].
Lebedev VP; Vodolazhskaia-Levina EE; Chemidze NP; Khovanskaia MP; Kalashnikova OA
Vopr Okhr Materin Det; 1971 Feb; 16(2):24-8. PubMed ID: 4933510
[No Abstract] [Full Text] [Related]
17. Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.
Magill SB
Compr Physiol; 2014 Jul; 4(3):1083-119. PubMed ID: 24944031
[TBL] [Abstract][Full Text] [Related]
18. Low-renin ("primary") hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome.
Ferriss JB; Beevers DG; Brown JJ; Fraser R; Lever AF; Padfield PL; Robertson JI
Am Heart J; 1978 May; 95(5):641-58. PubMed ID: 345789
[No Abstract] [Full Text] [Related]
19. [Normokalemic primary hyperaldosteronism].
Wolff HP; Barth C; Biro G; Bohle A; Dhom G; Distler A; Helber A; Liebau H; Purjesz I; Roscher S; Schürholz J; Vecsei P; Weinges KF
Klin Wochenschr; 1968 Apr; 46(7):357-70. PubMed ID: 5686105
[No Abstract] [Full Text] [Related]
20. [Adrenal cortex hormone secretion disorders and their clinical aspects].
Torikai T; Miura K; Goto K; Iino M; Sasaki T
Naika; 1967 Sep; 20(3):431-45. PubMed ID: 4296850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
